Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass

BackgroundThe inotropic drug levosimendan is often used as an individualized therapeutic approach perioperatively in cardiac surgery patients with cardiopulmonary bypass (CPB). Data regarding serum concentrations of levosimendan and its metabolites within this context is lacking.MethodsIn this retro...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Hannah Kipka, Uwe Liebchen, Max Hübner, Georg Höfner, Otto Frey, Klaus T. Wanner, Erich Kilger, Christian Hagl, Roland Tomasi, Hanna Mannell
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	levosimendan OR-1896 OR-1855 cardiac insufficiency cardiopulmonary bypass serum levels
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1406338/full